Wenjie Zhou , Yilin Li , Nan Lin , Zhiyu Cai , Chuanqing Mao , Yongzhen Lai , Meng Lu
{"title":"Comparison of the postoperative analgesic effects of bupivacaine and ropivacaine in infraorbital nerve block anesthesia for cheiloplasty in infants","authors":"Wenjie Zhou , Yilin Li , Nan Lin , Zhiyu Cai , Chuanqing Mao , Yongzhen Lai , Meng Lu","doi":"10.1016/j.ijporl.2025.112373","DOIUrl":null,"url":null,"abstract":"<div><h3>Obejective</h3><div>This prospective study aimed to evaluate the analgesic efficacy of ropivacaine and bupivacaine for infraorbital nerve block following cheiloplasty. Additionally, it investigated the safety and feasibility of these agents in infants and young children.</div></div><div><h3>Methods</h3><div>Participants were divided into three groups: Control (physiological saline), Group L (ropivacaine), and Group B (bupivacaine). Bilateral infraorbital nerve block anesthesia was performed at the beginning of surgery, followed by general anesthesia for the procedure. Postoperative pain was scored using the FLACC scale.</div></div><div><h3>Results</h3><div>Group B had a significantly lower heart rate post-surgery compared to the other groups (P < 0.05). FLACC pain scores at 30 min, 1 h, and 4 h post-surgery were significantly lower in Groups L and B compared to the control group (P < 0.05). Side effects included edema, hematoma, nausea, vomiting, cyanosis, and convulsions, with no adverse reactions in the control group. Group L had one case of lip cyanosis and convulsions, and Group B had one case of nausea and vomiting. No significant differences were found in age, weight, and surgical time among the three groups (P > 0.05).</div></div><div><h3>Conclusions</h3><div>Ropivacaine showed similar analgesic effects to bupivacaine but with higher safety for postoperative pain relief in cleft lip repair in infants and young children, suggesting its clinical utility.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":"193 ","pages":"Article 112373"},"PeriodicalIF":1.2000,"publicationDate":"2025-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of pediatric otorhinolaryngology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0165587625001600","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Obejective
This prospective study aimed to evaluate the analgesic efficacy of ropivacaine and bupivacaine for infraorbital nerve block following cheiloplasty. Additionally, it investigated the safety and feasibility of these agents in infants and young children.
Methods
Participants were divided into three groups: Control (physiological saline), Group L (ropivacaine), and Group B (bupivacaine). Bilateral infraorbital nerve block anesthesia was performed at the beginning of surgery, followed by general anesthesia for the procedure. Postoperative pain was scored using the FLACC scale.
Results
Group B had a significantly lower heart rate post-surgery compared to the other groups (P < 0.05). FLACC pain scores at 30 min, 1 h, and 4 h post-surgery were significantly lower in Groups L and B compared to the control group (P < 0.05). Side effects included edema, hematoma, nausea, vomiting, cyanosis, and convulsions, with no adverse reactions in the control group. Group L had one case of lip cyanosis and convulsions, and Group B had one case of nausea and vomiting. No significant differences were found in age, weight, and surgical time among the three groups (P > 0.05).
Conclusions
Ropivacaine showed similar analgesic effects to bupivacaine but with higher safety for postoperative pain relief in cleft lip repair in infants and young children, suggesting its clinical utility.
期刊介绍:
The purpose of the International Journal of Pediatric Otorhinolaryngology is to concentrate and disseminate information concerning prevention, cure and care of otorhinolaryngological disorders in infants and children due to developmental, degenerative, infectious, neoplastic, traumatic, social, psychiatric and economic causes. The Journal provides a medium for clinical and basic contributions in all of the areas of pediatric otorhinolaryngology. This includes medical and surgical otology, bronchoesophagology, laryngology, rhinology, diseases of the head and neck, and disorders of communication, including voice, speech and language disorders.